Cargando…

Vitamin D and Alzheimer's Disease: Neurocognition to Therapeutics

Alzheimer's disease (AD), the major cause of dementia worldwide, is characterized by progressive loss of memory and cognition. The sporadic form of AD accounts for nearly 90% of the patients developing this disease. The last century has witnessed significant research to identify various mechani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banerjee, Anindita, Khemka, Vineet Kumar, Ganguly, Anirban, Roy, Debashree, Ganguly, Upasana, Chakrabarti, Sasanka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553343/ https://www.ncbi.nlm.nih.gov/pubmed/26351614 http://dx.doi.org/10.1155/2015/192747

Ejemplares similares

Role of Pro-Inflammatory Cytokines and Vitamin D in Probable Alzheimer's Disease with Depression
por: Banerjee, Anindita, et al.
Publicado: (2017)

Serum 24‐hydroxycholesterol in probable Alzheimer's dementia: Reexploring the significance of a tentative Alzheimer's disease biomarker
por: Roy, Debashree, et al.
Publicado: (2019)

Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer's Disease
por: Ganguly, Upasana, et al.
Publicado: (2021)

Raised Serum Adenosine Deaminase Level in Nonobese Type 2 Diabetes Mellitus
por: Khemka, Vineet Kumar, et al.
Publicado: (2013)

Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
por: Ganguly, Upasana, et al.
Publicado: (2018)

Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease
por: Ganguly, Gargi, et al.
Publicado: (2017)

Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
por: Ganguly, Upasana, et al.
Publicado: (2021)

COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2020)

Visual contrast sensitivity could be an early marker of diabetic retinopathy
por: Pramanik, Subhasish, et al.
Publicado: (2020)

Vitamin D and neurocognitive function
por: Schlögl, Mathias, et al.
Publicado: (2014)

Vitamin D, Cognition and Alzheimer’s Disease: The Therapeutic Benefit is in the D-Tails
por: Landel, Véréna, et al.
Publicado: (2016)

Role of Vitamin D Supplementation in Prevention and Treatment of COVID-19
por: Khemka, Aakriti, et al.
Publicado: (2020)

Neuronal cell death mechanisms in Alzheimer’s disease: An insight
por: Goel, Parul, et al.
Publicado: (2022)

Exploring Neurocognitive Deterioration in Alzheimer’s Disease
por: Franzoni, Ferdinando, et al.
Publicado: (2023)

Therapeutic Potential of Vitamin D and Curcumin in an In Vitro Model of Alzheimer Disease
por: Alamro, Abir Abdullah, et al.
Publicado: (2020)

Dopamine Cytotoxicity Involves Both Oxidative and Nonoxidative Pathways in SH-SY5Y Cells: Potential Role of Alpha-Synuclein Overexpression and Proteasomal Inhibition in the Etiopathogenesis of Parkinson's Disease
por: Banerjee, Kalpita, et al.
Publicado: (2014)

Interdisciplinary Research in Alzheimer’s Disease and the Roles International Societies Can Play
por: Tan, Shawn Zheng Kai, et al.
Publicado: (2021)

Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products
por: Chakrabarti, Sasanka, et al.
Publicado: (2023)

Vitamin D deficiency: concern for rheumatoid arthritis and COVID-19?
por: Verma, Sneha, et al.
Publicado: (2021)

Vitamin D supplements: a novel therapeutic approach for Alzheimer patients
por: Annweiler, Cedric, et al.
Publicado: (2014)

Vitamin D and the risk of dementia and Alzheimer disease
por: Littlejohns, Thomas J., et al.
Publicado: (2014)

Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension
por: Saha, Sarama, et al.
Publicado: (2020)

Chronic Hepatitis B and Related Liver Diseases Are Associated with Reduced 25-Hydroxy-Vitamin D Levels: A Systematic Review and Meta-Analysis
por: Banerjee, Anindita, et al.
Publicado: (2023)

Neurocognitive trajectory and proteomic signature of inherited risk for Alzheimer’s disease
por: Paranjpe, Manish D., et al.
Publicado: (2022)

The Role of Vitamin D as a Biomarker in Alzheimer’s Disease
por: Bivona, Giulia, et al.
Publicado: (2021)

“Clinical Profile of Genetically Proven Huntington's Disease Patients from Eastern India”
por: Hussain, Zakir, et al.
Publicado: (2020)

Role of long non-coding RNAs and related epigenetic mechanisms in liver fibrosis (Review)
por: Ganguly, Niladri, et al.
Publicado: (2021)

Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2
por: Parashar, Nidarshana Chaturvedi, et al.
Publicado: (2020)

A comparative study of serum aminotransferases in chronic kidney disease with and without end-stage renal disease: Need for new reference ranges
por: Ray, Lopamudra, et al.
Publicado: (2015)

Computerized Neurocognitive Test (CNT) in mild cognitive impairment and Alzheimer's disease
por: de Oliveira, Maira Okada, et al.
Publicado: (2014)

A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders
por: Manzano, Sagrario, et al.
Publicado: (2020)

Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease
por: Aydin, Elber Yuksel, et al.
Publicado: (2020)

Composite neurocognitive endpoints in Alzheimer's disease clinical trials: A commentary
por: Randolph, Christopher
Publicado: (2020)

The role of PKC/PKR in aging, Alzheimer's disease, and perioperative neurocognitive disorders
por: Lu, Wenping, et al.
Publicado: (2022)

Psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence
por: Vasile, D., et al.
Publicado: (2021)

Metal Nanoparticles in Alzheimer’s Disease
por: Behera, Anindita, et al.
Publicado: (2023)

There is no evidence that vitamin D supplementation drives the progression of Alzheimer's disease
por: Gombart, Adrian F., et al.
Publicado: (2022)

The importance of Vitamin-D and Neutrophil-Lymphocyte Ratio for Alzheimer’s Disease
por: Evlice, Ahmet, et al.
Publicado: (2023)

Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
por: Kaur, Upinder, et al.
Publicado: (2020)

Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017–2019
por: Dutta, Anindita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1fshutrulq0chqc8c61782d57l